336 related articles for article (PubMed ID: 21351141)
21. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
[TBL] [Abstract][Full Text] [Related]
22. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
23. 20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism.
Kim WK; Meliton V; Amantea CM; Hahn TJ; Parhami F
J Bone Miner Res; 2007 Nov; 22(11):1711-9. PubMed ID: 17638575
[TBL] [Abstract][Full Text] [Related]
24. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
[TBL] [Abstract][Full Text] [Related]
25. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
26. Biglycan deficiency interferes with ovariectomy-induced bone loss.
Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
[TBL] [Abstract][Full Text] [Related]
27. Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.
Li M; Pan LC; Simmons HA; Li Y; Healy DR; Robinson BS; Ke HZ; Brown TA
Bone; 2006 Oct; 39(4):796-806. PubMed ID: 16759917
[TBL] [Abstract][Full Text] [Related]
28. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
[TBL] [Abstract][Full Text] [Related]
30. [Increasing alcohol-induced osteogenesis of human bone marrow-derived mesenchymal cells using siRNA transient suppression of peroxisome proliferator activated receptor gamma: an in vitro experiment study].
Zhang H; Cheng JQ; Huang Q; Yang J; Shen B; Zhou ZK; Kang PD; Lian YY; Pei FX
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2603-8. PubMed ID: 19080706
[TBL] [Abstract][Full Text] [Related]
31. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass.
Geoffroy V; Marty-Morieux C; Le Goupil N; Clement-Lacroix P; Terraz C; Frain M; Roux S; Rossert J; de Vernejoul MC
J Bone Miner Res; 2004 May; 19(5):811-22. PubMed ID: 15068505
[TBL] [Abstract][Full Text] [Related]
32. (-)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption.
Lee SH; Kim BJ; Choi HJ; Cho SW; Shin CS; Park SY; Lee YS; Lee SY; Kim HH; Kim GS; Koh JM
Calcif Tissue Int; 2012 May; 90(5):404-10. PubMed ID: 22434366
[TBL] [Abstract][Full Text] [Related]
33. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
34. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
35. Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis.
Usui M; Yoshida Y; Tsuji K; Oikawa K; Miyazono K; Ishikawa I; Yamamoto T; Nifuji A; Noda M
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6653-8. PubMed ID: 15100414
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
[TBL] [Abstract][Full Text] [Related]
37. Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation.
Zaiss MM; Sarter K; Hess A; Engelke K; Böhm C; Nimmerjahn F; Voll R; Schett G; David JP
Arthritis Rheum; 2010 Aug; 62(8):2328-38. PubMed ID: 20506516
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency.
Mohan S; Kapoor A; Singgih A; Zhang Z; Taylor T; Yu H; Chadwick RB; Chung YS; Donahue LR; Rosen C; Crawford GC; Wergedal J; Baylink DJ
J Bone Miner Res; 2005 Sep; 20(9):1597-610. PubMed ID: 16059632
[TBL] [Abstract][Full Text] [Related]
39. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
Iwaniec UT; Yuan D; Power RA; Wronski TJ
J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
[TBL] [Abstract][Full Text] [Related]
40. Physiological function of the angiotensin AT1a receptor in bone remodeling.
Kaneko K; Ito M; Fumoto T; Fukuhara R; Ishida J; Fukamizu A; Ikeda K
J Bone Miner Res; 2011 Dec; 26(12):2959-66. PubMed ID: 21887703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
